Mochida Pharmaceutical saw the highest growth of 1.99% in patent filings and 0.49% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.99% and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Mochida Pharmaceutical’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Mochida Pharmaceutical has been focused on protecting inventions in United States(US) with five publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 33% filings and 50% grants. The United States(US), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and Australia(AU) patent Office are among the top ten patent offices where Mochida Pharmaceutical is filings its patents. Among the top granted patent authorities, Mochida Pharmaceutical has 50% of its grants in United States(US) and 50% in Spain(ES).
Roche could be the strongest competitor for Mochida Pharmaceutical
Patents related to cell & gene therapy and rare diseases lead Mochida Pharmaceutical's portfolio
Mochida Pharmaceutical has the highest number of patents in cell & gene therapy followed by, rare diseases. For cell & gene therapy, nearly 50% of patents were filed and 100% of patents were granted in Q2 2024.
Petrochemicals related patents lead Mochida Pharmaceutical portfolio followed by orthopedic devices, and blood coagulation
Mochida Pharmaceutical has highest number of patents in petrochemicals followed by orthopedic devices, blood coagulation, hashimoto thyroiditis, and cosmetics & toiletries.
For comprehensive analysis of Mochida Pharmaceutical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
